Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Bangsberg

Showing results (201-210 of 390) with videos related to

Pageof 39
Sort By:
AIDS (London, England)|November 12, 2016
Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoringJessica E Haberer, Nicholas Musinguzi, Alexander C Tsai, et al.
BMC Public Health|September 28, 2018
Water insecurity and gendered risk for depression in rural Uganda: a hotspot analysisChristine E Cooper-Vince, Hawk Arachy, Bernard Kakuhikire, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2010
Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replicationJean-Jacques Parienti, Kathleen Ragland, Frédéric Lucht, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2009
Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approachElvin H Geng, David R Bangsberg, Nicolas Musinguzi, et al.
Journal of the International AIDS Society|March 24, 2020
Super learner analysis of real-time electronically monitored adherence to antiretroviral therapy under constrained optimization and comparison to non-differentiated care approaches for persons living with HIV in rural UgandaAlejandra E Benitez, Nicholas Musinguzi, David R Bangsberg, et al.
Plos One|July 5, 2012
Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVsMark J Siedner, Alexander Lankowski, Jessica E Haberer, et al.
SSM - Population Health|January 31, 2024
Social networks and HIV treatment adherence among people with HIV initiating treatment in rural Uganda and peri-urban South AfricaAlison B Comfort, Stephen Asiimwe, Gideon Amaniyre, et al.
Plos One|February 4, 2010
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV diseaseDavid M Naeger, Jeffrey N Martin, Elizabeth Sinclair, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2008
The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classesLily W Y Tam, Celia K S Chui, Chanson J Brumme, et al.
Plos Medicine|November 24, 2006
Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitatorsEdward J Mills, Jean B Nachega, David R Bangsberg, et al.
Pageof 39

Showing results (201-210 of 390) with videos related to

Sort By:
Pageof 39
AIDS (London, England)|November 12, 2016
Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoringJessica E Haberer, Nicholas Musinguzi, Alexander C Tsai, et al.
BMC Public Health|September 28, 2018
Water insecurity and gendered risk for depression in rural Uganda: a hotspot analysisChristine E Cooper-Vince, Hawk Arachy, Bernard Kakuhikire, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2010
Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replicationJean-Jacques Parienti, Kathleen Ragland, Frédéric Lucht, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2009
Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approachElvin H Geng, David R Bangsberg, Nicolas Musinguzi, et al.
Journal of the International AIDS Society|March 24, 2020
Super learner analysis of real-time electronically monitored adherence to antiretroviral therapy under constrained optimization and comparison to non-differentiated care approaches for persons living with HIV in rural UgandaAlejandra E Benitez, Nicholas Musinguzi, David R Bangsberg, et al.
Plos One|July 5, 2012
Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVsMark J Siedner, Alexander Lankowski, Jessica E Haberer, et al.
SSM - Population Health|January 31, 2024
Social networks and HIV treatment adherence among people with HIV initiating treatment in rural Uganda and peri-urban South AfricaAlison B Comfort, Stephen Asiimwe, Gideon Amaniyre, et al.
Plos One|February 4, 2010
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV diseaseDavid M Naeger, Jeffrey N Martin, Elizabeth Sinclair, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2008
The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classesLily W Y Tam, Celia K S Chui, Chanson J Brumme, et al.
Plos Medicine|November 24, 2006
Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitatorsEdward J Mills, Jean B Nachega, David R Bangsberg, et al.
Pageof 39